These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 4243221

  • 1. On the mechanism of the adrenergic nerve blocking action of bretylium.
    Haeusler G, Haefely W, Huerlimann A.
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 265(3):260-77. PubMed ID: 4243221
    [No Abstract] [Full Text] [Related]

  • 2. [On the mechanism of the adrenergic blocking action of bretylium and guanethidine].
    Haeusler G, Haefely W, Huerlimann A.
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):241-3. PubMed ID: 4242393
    [No Abstract] [Full Text] [Related]

  • 3. Interaction of phenoxybenzamine with guanethidine and bretylium at the sympathetic nerve endings of the isolated perfused spleen of the cat.
    Thoenen H, Huerlimann A, Haefely W.
    J Pharmacol Exp Ther; 1966 Feb; 151(2):189-95. PubMed ID: 5932597
    [No Abstract] [Full Text] [Related]

  • 4. Interactions of bretylium and acetylcholine at sympathetic nerve endings.
    Fischer JE, Weise VK, Kopin IJ.
    J Pharmacol Exp Ther; 1966 Sep; 153(3):523-9. PubMed ID: 5921529
    [No Abstract] [Full Text] [Related]

  • 5. The effects of bretylium on C fibre excitation and noradrenaline release by acetylcholine and electrical stimulation.
    Davey MJ, Hayden ML, Scholfield PC.
    Br J Pharmacol; 1968 Oct; 34(2):377-87. PubMed ID: 5687592
    [Abstract] [Full Text] [Related]

  • 6. Modification of sympathetic nerve stimulation frequency-response relationship in rabbit ileum by guanethidine, bretylium and tetracaine.
    Kihara M, Kubo T, Misu Y.
    Arch Int Pharmacodyn Ther; 1983 Dec; 266(2):180-5. PubMed ID: 6667066
    [Abstract] [Full Text] [Related]

  • 7. Effect of drugs on adrenergic nerve terminals.
    von Euler US.
    Adv Cytopharmacol; 1971 May; 1():363-7. PubMed ID: 4148190
    [No Abstract] [Full Text] [Related]

  • 8. Acetylcholine, bretylium and release of norepinephrine from sympathetic nerve endings.
    Kopin IJ.
    Ann N Y Acad Sci; 1967 Oct 31; 144(2):558-62. PubMed ID: 4295406
    [No Abstract] [Full Text] [Related]

  • 9. The actions of bretylium: adrenergic neurone blocking and other effects.
    BOURA AL, GREEN AF.
    Br J Pharmacol Chemother; 1959 Dec 31; 14(4):536-48. PubMed ID: 13803290
    [Abstract] [Full Text] [Related]

  • 10. Reversal of bretylium blockade of adrenergic nerve terminals by tetraethylammonium.
    Kirpekar M, Kirpekar SM, Prat JC.
    Biochem Pharmacol; 1978 May 15; 27(10):1512-3. PubMed ID: 697893
    [No Abstract] [Full Text] [Related]

  • 11. [On the mechanism of action of new drugs effective upon the autonomic and central nervous system].
    Oberdorf A, Hoffmeister F, Kroneberg G.
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967 May 15; 257(1):48-9. PubMed ID: 4231861
    [No Abstract] [Full Text] [Related]

  • 12. Selective depletion of noradrenaline: a proposed mechanism of the adrenergic neurone-blocking action of bretylium.
    Abbs ET, Robertson MI.
    Br J Pharmacol; 1970 Apr 15; 38(4):776-91. PubMed ID: 5441790
    [Abstract] [Full Text] [Related]

  • 13. The effects of guanethidine, bretylium and debrisoquine on the accumulation of noradrenaline in constricted postganglionic sympathetic nerves in vitro.
    Tomlinson DR, Mayor D.
    Eur J Pharmacol; 1973 Feb 15; 21(2):161-70. PubMed ID: 4696099
    [No Abstract] [Full Text] [Related]

  • 14. The effects of 6-hydroxydopamine on vagal cardioaccelerator systems.
    Alter WA, Weiss GK, Priola DV, Spurgeon HA.
    J Pharmacol Exp Ther; 1973 Oct 15; 187(1):99-104. PubMed ID: 4746337
    [No Abstract] [Full Text] [Related]

  • 15. Role of the adrenergic nerve terminal in digitalis-induced cardiac toxicity: a study of the effects of pharmacological and surgical denervation.
    Lathers CM, Gerard-Ciminera JL, Baskin SI, Krusz JC, Kelliher GJ, Goldberg PB, Roberts J.
    J Cardiovasc Pharmacol; 1982 Oct 15; 4(1):91-8. PubMed ID: 6176806
    [Abstract] [Full Text] [Related]

  • 16. Effect of bretylium on adrenergic neurons and its relation to sodium.
    Misu Y, Kubo T.
    Jpn J Pharmacol; 1974 Apr 15; 24(2):332-4. PubMed ID: 4546785
    [No Abstract] [Full Text] [Related]

  • 17. The action of acetyl choline and other drugs upon the terminal parts of the postganglionic sympathetic fibre.
    Cabrera R, Torrance RW, Viveros H.
    Br J Pharmacol Chemother; 1966 May 15; 27(1):51-63. PubMed ID: 5961470
    [No Abstract] [Full Text] [Related]

  • 18. Growth inhibition of sympathetic cells by some adrenergic blocking agents (6-hydroxydopamine-mice and rats-immunosympathectomy-chemical sympathectomy-superior cervical ganglion).
    Angeletti PU, Levi-Montalcini R.
    Proc Natl Acad Sci U S A; 1972 Jan 15; 69(1):86-8. PubMed ID: 4333047
    [Abstract] [Full Text] [Related]

  • 19. [Ultrastructural modifications induced by several drugs on adrenergic nerve endings and on the adrenal medulla].
    Clementi F.
    Experientia; 1965 Mar 15; 21(3):171-6. PubMed ID: 5890429
    [No Abstract] [Full Text] [Related]

  • 20. Characteristics and mechanism of inotropic and chronotropic actions of bretylium tosylate.
    Markis JE, Koch-Weser J.
    J Pharmacol Exp Ther; 1971 Jul 15; 178(1):94-102. PubMed ID: 5087408
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.